Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidence. - Zanichelli A; Wuillemin WA; Aygören-Pürsün E; Banerji A; Busse PJ; Betschel SD; Cancian M; Gagnon R; Goodyear MD; Kinaciyan T; Kessel A; Magerl M; et al. (Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2025)